Email a Friend
To: (email address)
From: (email address)
Email Subject:
Note: (optional)
255 character limit
In this section, you can review LDL cholesterol reduction results and LDL cholesterol goal attainment results from comparative clinical trials in which CRESTOR® (rosuvastatin calcium) was used as an adjunct to diet in patients who switched statin therapy.
See how CRESTOR performed in lowering LDL cholesterol compared to other statins.
For detailed comparative clinical trial data, select the appropriate tab below.
Click on the "+" and "—" signs to expand and collapse the clinical information.
‡Subject to eligibility. Restrictions apply. Click here for eligibility information.
Goal attainment (LDL-C <100 mg/dL) in patients at high risk* of CHD, switching to CRESTOR vs remaining on atorvastatin2
Adapted from the MERCURY II Trial
Goal attainment (LDL-C <100 mg/dL) in patients at high risk* of CHD switching to CRESTOR vs remaining on simvastatin2
Adapted from the MERCURY II Trial
Lipitor is a registered trademark of Pfizer Inc.
You may report side effects related to AstraZeneca products by clicking here.